skip to content
Diabetes at Work


Planning Guide

Assessment Tool

Choosing a Health Plan

Lesson Plans

Fact Sheets

Diabetes At Work Workshops


Frequently Asked Questions (FAQ's)
 Diabetes and Health Resource Kit Banner

Skip the How to Choose a Health Plan Navigation tableAssessment Tool: Assessing Diabetes in Your Company

Facts About Diabetes

Conducting an Assessment

Additional Resources



  1. American Diabetes Association, Economic Costs of Diabetes in the US in 2002. Diabetes Care 2003;26:917-932.
  2. Burton WN, Connerty CM. Evaluation of a worksite-based patient education intervention targeted at employees with diabetes mellitus. J Occup Environ Med 1998;40(8):702–6.
  3. Centers for Disease Control, Prevalence of Diabetes and Impaired Fasting Glucose in Adults- United States 1999-2000, MMWR September 5, 2003/ 52(35):833-837.
  4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329(14):977–86.
  5. Diabetes Prevention Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2003;346:393-403.
  6. Gilmer TP, O'Connor P, Manning WG, Rush WA. The cost to health plans of poor glycemic control. Diabetes Care 1997;20(12):1847–53.
  7. Harris,M, Flegal K, Cowie C et al. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults: The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-24
  8. Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 2001;24(1):51-5.
  9. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM. Diabetes trends in the US: 1990–1998. Diabetes Care 2000;23(9):1278–83.
  10. Mokdad A, Ford E, Bowman B, Nelson D, Engelgau M, Vinicor F, Marks J. The continuing increase of diabetes in the US. Diabetes Care 2001;24(2):412.
  11. National Institutes of Health, National Diabetes Fact Sheet: National estimates of diabetes in the US 1997 and 2002 (
  12. Ng YC, Jacobs P, Johnson JA. Productivity losses associated with diabetes in the US. Diabetes Care 2001;24(2):257–61.
  13. Testa MA, Simonsen DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled clinical trial. JAMA 1998;280(17):1490–6.
  14. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837–53.
  15. Wagner E, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA 2001;285(2):182–9.


skip redundant bottom navigation and and refresh the page


Go to Home Page Go to Home Page Go to About Page Go to FAQ's Page Go to Feedback Form Go to Contact Us Page